Literature DB >> 9631844

Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis.

M Kawamura1, S Fijimoto, S Hisanaga, Y Yamamoto, T Eto.   

Abstract

We retrospectively investigated the incidence and prognosis of and risk factors for cerebrovascular events in 1,064 patients with chronic uremia who received maintenance hemodialysis (HD) for more than 3 months during 24 years in our dialysis units in Miyazaki, Japan. Cerebrovascular events developed in 98 patients (9.2%). The confirmed incidences of cerebral hemorrhage (CH) and infarction were 8.7 and 3.7 per 1,000 patient-years, respectively. Of the 56 patients with CH, 40 (71.4%) died within 3 months of the onset of CH. Ganglio-thalamic lesion was observed in 32 (80.0%) of 40 patients with CH confirmed by a brain computed tomography. The incidence of polycystic kidney disease was higher in the CH group than in the overall HD population (12.5% v 3.9%, P < 0.01). Of the 13 patients with diabetes mellitus and nephrosclerosis, nine (69.2%) developed CH within 36 months of the initiation of HD; 11 (78.6%) of 14 patients with chronic glomerulonephritis developed CH after 36 months. CH developed in six patients (15.0%) within 6 hours of a previous HD session. We compared laboratory values, the supine blood pressure, and electrocardiographic (ECG) findings in 35 patients with CH and a control group (66 patients) matched in age, sex, basal renal disease, age at the initiation of HD, and the duration of HD. Data were obtained before and after HD 3 to 4 months before the first attack of CH. The systolic and diastolic blood pressure (SBP, DBP) before and after HD were significantly higher in the CH group than in the control group (pre-HD SBP: 171 +/- 22.5 v 154 +/- 19.3 mm Hg, P < 0.001; pre-HD DBP: 89 +/- 13.6 v 81 +/- 9.6 mm Hg, P < 0.001). The incidence of left ventricular hypertrophy was higher, and the Kt/V was significantly lower (1.23 +/- 0.26 v 1.38 +/- 0.34, P < 0.05) in the CH group than in the control group. However, there were no significant differences in the serum levels of albumin and cholesterol or the total dose of heparin during HD sessions between groups. In conclusion, the incidence of CH was high, and its prognosis was poor, in patients undergoing maintenance HD. Reversible risk factors include hypertension and possibly the amount of HD prescribed, but not anticoagulation with heparin.

Entities:  

Mesh:

Year:  1998        PMID: 9631844     DOI: 10.1053/ajkd.1998.v31.pm9631844

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  38 in total

1.  Prognostic implications of chronic kidney disease and anemia after percutaneous coronary intervention in acute myocardial infarction patients.

Authors:  Yuya Matsue; Akihiko Matsumura; Masami Abe; Maki Ono; Mie Seya; Tomofumi Nakamura; Ryota Iwatsuka; Akira Mizukami; Masahiko Setoguchi; Wataru Nagahori; Masakazu Ohno; Makoto Suzuki; Yuji Hashimoto
Journal:  Heart Vessels       Date:  2011-12-10       Impact factor: 2.037

Review 2.  Chronic kidney disease in the pathogenesis of acute ischemic stroke.

Authors:  Bharath Chelluboina; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2019-08-01       Impact factor: 6.200

3.  Relation between intracranial artery calcifications and aortic atherosclerosis in ischemic stroke patients.

Authors:  Jean-Marc Bugnicourt; Jean-Marc Chillon; Christophe Tribouilloy; Sandrine Canaple; Chantal Lamy; Ziad A Massy; Olivier Godefroy
Journal:  J Neurol       Date:  2010-03-31       Impact factor: 4.849

Review 4.  Treatment of hypertension in the hemodialysis patient: beneficial or not?

Authors:  M M Salem
Journal:  Curr Hypertens Rep       Date:  2000-10       Impact factor: 5.369

Review 5.  Treatment of Central Nervous System Complications of Renal Dialysis and Transplantation.

Authors:  Samer Dahdaleh; Paresh Malhotra
Journal:  Curr Treat Options Neurol       Date:  2019-03-11       Impact factor: 3.598

6.  Lower serum calcium and pre-onset blood pressure elevation in cerebral hemorrhage patients undergoing hemodialysis.

Authors:  Mineaki Kitamura; Yohei Tateishi; Shuntaro Sato; Yuki Ota; Kumiko Muta; Tadashi Uramatsu; Tsuyoshi Izumo; Yasushi Mochizuki; Takashi Harada; Satoshi Funakoshi; Takayuki Matsuo; Akira Tsujino; Hideki Sakai; Hiroshi Mukae; Tomoya Nishino
Journal:  Clin Exp Nephrol       Date:  2020-01-14       Impact factor: 2.801

Review 7.  Chronic dialysis in patients with end-stage renal disease: Relevance to kidney xenotransplantation.

Authors:  Abhijit Jagdale; David K C Cooper; Hayato Iwase; Robert S Gaston
Journal:  Xenotransplantation       Date:  2018-11-20       Impact factor: 3.907

8.  Stroke in chronic kidney disease.

Authors:  P Rama Krishna; S Naresh; G S R Krishna; A Y Lakshmi; B Vengamma; V Siva Kumar
Journal:  Indian J Nephrol       Date:  2009-01

9.  Major bleeding events and risk stratification of antithrombotic agents in hemodialysis: results from the DOPPS.

Authors:  Manish M Sood; Maria Larkina; Jyothi R Thumma; Francesca Tentori; Brenda W Gillespie; Shunichi Fukuhara; David C Mendelssohn; Kevin Chan; Patricia de Sequera; Paul Komenda; Claudio Rigatto; Bruce M Robinson
Journal:  Kidney Int       Date:  2013-05-15       Impact factor: 10.612

10.  Atrial fibrillation and risk of stroke in dialysis patients.

Authors:  James B Wetmore; Edward F Ellerbeck; Jonathan D Mahnken; Milind Phadnis; Sally K Rigler; Purna Mukhopadhyay; John A Spertus; Xinhua Zhou; Qingjiang Hou; Theresa I Shireman
Journal:  Ann Epidemiol       Date:  2013-01-16       Impact factor: 3.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.